European Meeting on HIV & Hepatitis 2024

The Role of Social and Structural Determinants on Access to PrEP | Michael Meulbroek

Slideset

HIV

Viral Hepatitis and Liver Disease

RSV

COVID-19

Charles Boucher Lecture - Resistance Testing in Routine Care: What a Clinician Needs to Know | Daniele Armenia

Slideset

HIV

Viral Hepatitis and Liver Disease

RSV

COVID-19

Andrea De Luca Lecture - Low Level Viremia: Is It Clinically Relevant? | Annemarie Wensing

Slideset

HIV

Viral Hepatitis and Liver Disease

RSV

COVID-19

Personalized Treatment Regimens | Josep M. Llibre

Slideset

HIV

Viral Hepatitis and Liver Disease

RSV

COVID-19

Women’s Health Throughout the Life Cycle | Oana Săndulescu

Slideset

HIV

Viral Hepatitis and Liver Disease

RSV

COVID-19

Oral Abstract Presentation #1 | Promise Taiwo

Slideset

HIV

Viral Hepatitis and Liver Disease

RSV

COVID-19

Oral Abstract Presentation #2 | Sohaib Khan

Slideset

HIV

Viral Hepatitis and Liver Disease

RSV

COVID-19

Oral Abstract Presentation #3 | Elisa Teyssou

Slideset

HIV

Viral Hepatitis and Liver Disease

RSV

COVID-19

Oral Abstract Presentation #4 | Daniele Armenia

Slideset

HIV

Viral Hepatitis and Liver Disease

RSV

COVID-19

Oral Abstract Presentation #5 | Basma Abdi

Slideset

HIV

Viral Hepatitis and Liver Disease

RSV

COVID-19

Oral Abstract Presentation #6 | Enagnon Kazali Alidjinou

Slideset

HIV

Viral Hepatitis and Liver Disease

RSV

COVID-19

Oral Abstract Presentation #7 | Martin Däumer

Slideset

HIV

Viral Hepatitis and Liver Disease

RSV

COVID-19

Oral Abstract Presentation #8 | Margarida Veloso

Slideset

HIV

Viral Hepatitis and Liver Disease

RSV

COVID-19

Oral Abstract Presentation #9 | Pablo Ferrer

Slideset

HIV

Viral Hepatitis and Liver Disease

RSV

COVID-19

Oral Abstract Presentation #10 | Maria Mercedes Santoro

Slideset

HIV

Viral Hepatitis and Liver Disease

RSV

COVID-19

Oral Abstract Presentation #11 | Karol Serwin

Slideset

HIV

Viral Hepatitis and Liver Disease

RSV

COVID-19

Oral Abstract Presentation #12 | Kristi Huik

Slideset

HIV

Viral Hepatitis and Liver Disease

RSV

COVID-19

RSV Immunoprophylaxis: Where Are We and What Is the Impact on Viral Genetic Diversity | Slim Fourati

Slideset

HIV

Viral Hepatitis and Liver Disease

RSV

COVID-19

Oral Abstract Presentation #13 | Alessia Lai

Slideset

HIV

Viral Hepatitis and Liver Disease

RSV

COVID-19

Oral Abstract Presentation #14 | Annalisa Bergna

Slideset

HIV

Viral Hepatitis and Liver Disease

RSV

COVID-19

Oral Abstract Presentation #15 | Bryan Jimenez Araya

Slideset

HIV

Viral Hepatitis and Liver Disease

RSV

COVID-19

Oral Abstract Presentation #16 | Rossana Scutari

Slideset

HIV

Viral Hepatitis and Liver Disease

RSV

COVID-19

Oral Abstract Presentation #17 | Aurelie Minelle Kengni Ngueko

Slideset

HIV

Viral Hepatitis and Liver Disease

RSV

COVID-19

Oral Abstract Presentation #18 | Théophile Cocherie

Slideset

HIV

Viral Hepatitis and Liver Disease

RSV

COVID-19

Oral Abstract Presentation #19 | Ana B. Abecasis

Slideset

HIV

Viral Hepatitis and Liver Disease

RSV

COVID-19

Oral Abstract Presentation #21 | Collins Ambe Chenwi

Slideset

HIV

Viral Hepatitis and Liver Disease

RSV

COVID-19

Debate: Clinical Value of Proviral DNA Resistance Testing - PRO | Francesca Ceccherini-Silberstein

Slideset

HIV

Viral Hepatitis and Liver Disease

RSV

COVID-19

Debate: Clinical Value of Proviral DNA Resistance Testing - CON | Anne-Geneviève Marcelin

Slideset

HIV

Viral Hepatitis and Liver Disease

RSV

COVID-19

Update on the GS HIV Pipeline: A Focus on Treatment and Prevention | Calvin Cohen

Slideset

HIV

Viral Hepatitis and Liver Disease

RSV

COVID-19

Update on the MSD HIV Pipeline: Prevention, Treatment, and Cure | Rafael Eduardo Campo

Slideset

HIV

Viral Hepatitis and Liver Disease

RSV

COVID-19

Acute HCV and Reinfection | Loreta Kondili

Slideset

HIV

Viral Hepatitis and Liver Disease

RSV

COVID-19

Oral Abstract Presentation #22 | Stefano D'Anna

Slideset

HIV

Viral Hepatitis and Liver Disease

RSV

COVID-19

Oral Abstract Presentation #23 | Lorenzo Piermatteo

Slideset

HIV

Viral Hepatitis and Liver Disease

RSV

COVID-19

European Meeting on HIV & Hepatitis 2024

The Role of Social and Structural Determinants on Access to PrEP | Michael Meulbroek

Resistance Considerations in Choosing PrEP Across Europe | Anna Maria Geretti

Prevention of STIs: The Role of Doxy-PEP | Deniz Gökengin

Weight Gain and ARV Therapy: What a Clinician Needs to Know | Laura Waters

Charles Boucher Lecture - Resistance Testing in Routine Care: What a Clinician Needs to Know | Daniele Armenia

Andrea De Luca Lecture - Low Level Viremia: Is It Clinically Relevant? | Annemarie Wensing

Personalized Treatment Regimens | Josep M. Llibre

Women’s Health Throughout the Life Cycle | Oana Săndulescu

Oral Abstract Presentation #1 | Promise Taiwo

Oral Abstract Presentation #2 | Sohaib Khan

Oral Abstract Presentation #3 | Elisa Teyssou

Oral Abstract Presentation #4 | Daniele Armenia

Oral Abstract Presentation #5 | Basma Abdi

Oral Abstract Presentation #6 | Enagnon Kazali Alidjinou

Oral Abstract Presentation #7 | Martin Däumer

Oral Abstract Presentation #8 | Margarida Veloso

Oral Abstract Presentation #9 | Pablo Ferrer

Oral Abstract Presentation #10 | Maria Mercedes Santoro

Oral Abstract Presentation #11 | Karol Serwin

Oral Abstract Presentation #12 | Kristi Huik

RSV Immunoprophylaxis: Where Are We and What Is the Impact on Viral Genetic Diversity | Slim Fourati

Oral Abstract Presentation #13 | Alessia Lai

Oral Abstract Presentation #14 | Annalisa Bergna

Oral Abstract Presentation #15 | Bryan Jimenez Araya

Oral Abstract Presentation #16 | Rossana Scutari

Oral Abstract Presentation #17 | Aurelie Minelle Kengni Ngueko

Oral Abstract Presentation #18 | Théophile Cocherie

Oral Abstract Presentation #19 | Ana B. Abecasis

Oral Abstract Presentation #21 | Collins Ambe Chenwi

Debate: Clinical Value of Proviral DNA Resistance Testing - PRO | Francesca Ceccherini-Silberstein

Debate: Clinical Value of Proviral DNA Resistance Testing - CON | Anne-Geneviève Marcelin

Update on the GS HIV Pipeline: A Focus on Treatment and Prevention | Calvin Cohen

Update on the MSD HIV Pipeline: Prevention, Treatment, and Cure | Rafael Eduardo Campo

Acute HCV and Reinfection | Loreta Kondili

Oral Abstract Presentation #22 | Stefano D'Anna

Oral Abstract Presentation #23 | Lorenzo Piermatteo

Addressing Late HIV Presentation: A Stubborn Unmet Need | Anca Streinu-Cercel